Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7348 p538
7 May 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Standards of asthma care not met in Europe

Most people with asthma in Europe do not receive adequate standards of care, a survey carried out by the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) has revealed.

EFA surveyed 1,300 people with severe asthma in the UK, France, Spain, Germany and Sweden. It found that 90 per cent of people are not achieving one or more of the five treatment goals recommended by the Global Initiative for Asthma. These are:

· To prevent troublesome symptoms
· To prevent serious attacks
· To require little or no reliever medication
· To lead productive, physically active lives
· To have (near) normal lung function

More than a third of respondents said that asthma prevents them going out and socialising with friends, a fifth believe that it damages their career or studies and seven in 10 said it prevents them from enjoying an active life.

When questioned about the future, more than half of respondents said they expect little improvement in asthma management, however 71 per cent are hoping there will be advances in research and medication within the next five years.

The EFA is calling on the European Community to honour its promise of “a high level of protection” for EU citizens by issuing regulations for clean air, including a ban on smoking in all public places. It is also calling for new guidelines on health care accessibility and funding for people with asthma and more funding for public awareness campaigns.

The full report “Fighting for breath: a European patient perspective on severe asthma” will be published in September.

Back to Top


©The Pharmaceutical Journal